An opioid made in the brain is crucial for remembering others
It would be inconvenient if we couldn’t remember the people we have or haven’t met before. Social recognition, the ability to differentiate familiar or novel individuals of the same species is part of a larger process of social memory that allows groups within a species to build and maintain stable networks or relationships, like what we know as friend groups or communities.
The hippocampus, known for its role in memory, is divided into subregions that contribute to different memory processes, and one called CA2 is particularly important for social memory. Scientists have found one particular neurochemical to be important in social recognition. Enkephalin, a neuropeptide that interacts with opioid receptors, is needed in CA2 to recognize new people.
Enkephalins belong to a class of opioids produced by the brain which are often associated with stress response and pain relief. The researchers found that in CA2, these compounds are released by specific type of neuron, boosting information transfer to the CA2, thus enabling our brains to form social memories.
Scientists studied the effects of enkephalin through a social memory test in mice. They introduced one mouse to a space with two others, and the subject mouse was allowed to interact with each mouse for fiver minutes. The subject mouse was removed, then returned half an hour later, this time with one of the mice from the last entry and one mouse it had not met before. The typical response for mice in this case is to pay attention to the new mouse for longer. The scientists observed that, while mice with regular enkephalin levels sniffed out the new mouse for a longer amount of time, mice without enkephalin spent the same amount of time between both mice, as if they had not previously encountered one of them.
A better understanding of social memory can help demystify related diseases. Schizophrenia, a condition in which social memory is impaired, is treated with drugs affecting opioid receptors, for example. The results of this study shed light on how these treatments work.
This story originally appeared on Massive Science, an editorial partner site that publishes science stories by scientists. Subscribe to their newsletter to get even more science sent straight to you.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Cells have more mini ‘organs’ than researchers thought
Membraneless organelles, also called biomolecular condensates, are changing how scientists think about protein chemistry, various diseases and even the origin of life.
Institute launches a new AI initiative to power biological research
Stowers investigator Julia Zeitlinger selected to head effort and leverage cutting-edge computational techniques to accelerate scientific discoveries.
From the journals: JLR
Fixation method to quantify brain metabolites. Belly fat and liver disease crosstalk. Stopping heart diseases in schizophrenic patients. Read about the recent JLR papers on these topics.
Does a protein hold the key to Alzheimer’s?
Researchers in Maryland and Massachusetts team up to study how SORL1 promotes tau trafficking and seeding in cells that leads to the neurodegenerative disorder.
Cracking the recipe for perfect plant-based eggs
It involves finding just the right proteins. With new ingredients and processes, the next generation of substitutes will be not just more egg-like, but potentially more nutritious.
MSU researchers leverage cryo-EM for decades-in-the-making breakthrough
Lee Kroos and Ben Orlando have reported the first high-resolution experimentally determined structures of the intramembrane protease SpolVFB.